This study suggested that the Keap1-Nrf2-AKR1C1 axis was the downstream regulatory target of YTHDF1, emphasizing the important character of YTHDF1 in hypoxia adjustment and NSCLC progression (Shi et al., 2019). This evidence concerns the gene KEAP1 and non-small cell lung carcinoma.